BIOSECURE bill targets more Chinese companies as biotechs and their customers adapt to defunding
US regulators have added more Chinese biotech companies to the list of firms posing national security risks to the US.
US regulators have added more Chinese biotech companies to the list of firms posing national security risks to the US.
GSK, Lundbeck, and ROVI share how their events strategies contribute to higher-value engagement with healthcare professionals (HCPs). By Jenna Sherlock-Goudet, Veeva's Director of Commercial Strategy, Europe.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
NIH team develops AI tool to predict cancer drug response
TetraScience and Google Cloud link for AI-driven drug developments
Bayer and Google Cloud to develop AI solutions for radiologists
Q&A: BARDA wants to back tech that can combat multiple infections, says director